healio.com /2 weeks ago

Ulcerative colitis symptoms improve within 1 week of treatment with obefazimod

NASHVILLE, Tenn. — Treatmet with obefazimod resulted in clinically meaningful improvements in ulcerative colitis symptoms within 1 week of treatment with increased improvement over...

Read source
kevinmd.com /1 month ago

Functional recovery after hospitalization starts early

We know when a patient’s laboratory values have improved. We know when the infection has cleared, the fracture has been repaired, or the heart failure has stabilized. But before de...

Read source
healio.com /6 days ago

First-in-class therapy may improve clinical remission in ulcerative colitis

A receptor-interacting protein kinase 2 scaffolding inhibitor significantly improved clinical remission in moderately to severely active ulcerative colitis, according to results pr...

Read source
healio.com /6 days ago

First-in-class therapy may improve clinical remission in ulcerative colitis

A receptor-interacting protein kinase 2 scaffolding inhibitor significantly improved clinical remission in moderately to severely active ulcerative colitis, according to results pr...

Read source
healio.com /1 month ago

Oral icotrokinra sustains UC response through 76 weeks

NASHVILLE, Tenn. — Investigational oral interleukin-23 inhibitor icotrokinra sustained efficacy and favorable tolerability through week 76 in patients with moderately to severely a...

Read source
healio.com /3 weeks ago

Guselkumab improves long-term histologic outcomes in patients with ulcerative colitis

NASHVILLE, Tenn. — The dual-acting interleukin-23 inhibitor guselkumab improved histologic outcomes in patients with moderately to severely active ulcerative colitis over a 3-year...

Read source
healio.com /4 weeks ago

Subcutaneous infliximab outperforms IV maintenance in ileal Crohn’s

NASHVILLE, Tenn. — Patients with ileal Crohn’s disease had significantly better clinical and endoscopic outcomes at week 54 with subcutaneous vs. IV infliximab therapy, according t...

Read source
healio.com /1 week ago

Vedolizumab may prolong time to first ulcerative colitis-related complication

Patients with ulcerative colitis treated with intravenous vedolizumab reached corticosteroid-free disease clearance by 16 weeks, according to results of the VERDICT trial presented...

Read source
bioengineer.org /1 month ago

Combination therapy improves heart failure measures in retrospective Chinese cohort

A retrospective study of 150 Chinese heart-failure patients found that adding dapagliflozin to sacubitril-valsartan was associated with better cardiac-function measures, lower biom...

Read source
parkinsonsnewstoday.com /3 weeks ago

Oral therapy shows encouraging results for early Parkinson’s disease

In a small proof-of-concept clinical trial, Biovie’s experimental oral therapy bezisterim was associated with significantly greater improvements in motor and nonmotor symptom score...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.